Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen

Citation
Ps. Heeger et al., Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen, J IMMUNOL, 165(3), 2000, pp. 1278-1284
Citations number
56
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
165
Issue
3
Year of publication
2000
Pages
1278 - 1284
Database
ISI
SICI code
0022-1767(20000801)165:3<1278:CAODSF>2.0.ZU;2-3
Abstract
T cell immunity is often focused on one peptide segment of a complex protei n Ag, with other epitopes inducing weaker, low frequency responses or no re sponses at all. Such determinant hierarchy has been well characterized for MHC class II-restricted CD4 cell immunity, but is less well understood for class I-restricted CD8 cell responses. We studied class I determinant recog nition in a skin transplant model with beta-galactosidase (beta-gal) as a m inor transplantation Ag, CD8 T cells from C57BL/6 mice that rejected congen ic C57BL/6 beta-gal transgenic skin were tested in enzyme-linked immunospot assays for recall responses to single-step, overlapping, 9-mer peptides th at spanned a 94-aa region of the beta-gal sequence. This approach provided every possible class I-restricted peptide for CD8 cell recognition, allowin g us to define the in vivo frequency of CD8 cells specific for each of the 86 individual peptides. While four peptides were predicted to bind to the K -b or D-b molecules, only one (beta-gal(96-103)) actually induced an immune response. No peptides outside of the motifs were recognized. Tolerization to beta-gal(96-103) significantly prolonged beta-gal transgenic skin graft survival, confirming its immune dominance. Therefore, single-determinant do minance characterized this CD8 cell response. The data demonstrate the feas ibility of large-scale, comprehensive, class I determinant mapping, an appr oach that should be indispensable in measuring CD8 cell immunity in humans.